OrderlyMeds
- Company typePrivate
- Founded2023
- HeadquartersAtlanta, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
OrderlyMeds firmographics
Firmographics- Name
- OrderlyMeds
- Legal name
- OrderlyMeds LLC
- Website
- https://orderlymeds.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
OrderlyMeds industry classification
Industry- Product category
- Direct-to-consumer telemedicine weight management
- NAICS
- Offices of Physicians (6211), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industries
- Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH), Medication Reconciliation & Treatment Adherence Coordination (HSABAIAE)
Keywords
Where OrderlyMeds is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
OrderlyMeds business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- GLP-1 Medication Sales: Monthly subscription-style payments for GLP-1 and GLP-1/GIP medications, including both compounded formulations and brand-name drugs (Wegovy, Zepbound). Pricing is tiered with starter programs at discounted rates transitioning to standard monthly rates. No membership fees, no hidden costs. HSA/FSA accepted.
- Affiliate Program: One-time commission payments of $75 for each new customer referred through the affiliate program, plus $25 bonus for each sub-affiliate onboarded.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Compounded GLP-1/GIP (Tirzepatide) Starter Program |
| Subscription | Monthly | Compounded GLP-1/GIP (Tirzepatide) Transfer Program |
| Subscription | Monthly | Compounded GLP-1 (Semaglutide) Starter Program |
| Subscription | Monthly | Compounded GLP-1 (Semaglutide) Transfer Program |
| Subscription | Monthly | Zepbound (Brand-name GLP-1/GIP) |
| Subscription | Monthly | Wegovy (Brand-name GLP-1) |
| Subscription | Monthly | NAD+ Longevity Treatment |
| Subscription | Monthly | Sermorelin Longevity Treatment |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
OrderlyMeds product offering
Product offeringCore offering
OrderlyMeds is a direct-to-consumer telemedicine platform that connects individual patients with licensed healthcare providers in all 50 U.S. states to obtain GLP-1 and GLP-1/GIP weight loss medications, including compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound, delivered directly to the patient's door. The all-inclusive monthly subscription bundles provider consultations, medication, syringes, and shipping, and is supplemented by a wellness ecosystem of online therapy, fitness, nutrition, and peer community support. The company recently extended the offering into longevity care with compounded NAD+ and Sermorelin add-on therapies for existing GLP-1 patients.
Product overview
OrderlyMeds is a telemedicine platform providing GLP-1 and GLP-1/GIP weight loss medications with integrated telehealth consultations. The core portfolio centers on Compounded Semaglutide (from $74/mo) and Compounded Tirzepatide (from $149/mo), alongside branded alternatives Wegovy and Zepbound. The platform expanded into longevity wellness with Compounded NAD+ and Compounded Sermorelin treatments. Supporting the medication program is a suite of educational tools including calorie, TDEE, BMI, protein, and weight loss calculators, plus a mobile app, expert webinars, and a private peer community. OrderlyMeds connects patients with licensed healthcare professionals across all 50 states, offering personalized dosing, ongoing provider support, and comprehensive care resources.
Differentiator
Problem solved
Functional benefit
Products and services
- Compounded GLP-1 (Semaglutide) Compounded semaglutide injection for GLP-1 weight loss treatment, formulated to support individual patient needs with personalized dosing and titration. May include supportive supplements such as B6 or B12 as selected by the prescriber. Prescribed by state-licensed providers via OrderlyMeds' telehealth platform and shipped to patients in all 50 U.S. states from 503A compounding pharmacies. Available via SimpleStart starter program at $74/month for 2 months then $149/month, or a transfer program at $112/month for patients already on GLP-1 therapy.
- Compounded GLP-1/GIP (Tirzepatide) Compounded tirzepatide injection combining GLP-1 and GIP receptor agonism for enhanced weight loss, with personalized dosing and optional supportive supplements such as B6 or B12 as selected by the prescriber. Prescribed via OrderlyMeds' telehealth platform and shipped from U.S. 503A compounding pharmacies. Available via SimpleStart starter at $149/month for 2 months then $299/month, or a transfer program at $224/month for patients already on GLP-1 therapy.
- Wegovy (Semaglutide Brand) FDA-approved brand-name semaglutide 2.4mg injection for chronic weight management, prescribed and dispensed through OrderlyMeds' telehealth platform with ongoing provider support. Available in doses of 0.25mg, 0.5mg, and 1mg, priced at $1,839/month.
- Zepbound (Tirzepatide Brand) FDA-approved brand-name tirzepatide injection mimicking both GLP-1 and GIP hormones for weight loss, prescribed and dispensed through OrderlyMeds' telehealth platform with ongoing provider support. Available in doses from 2.5mg to 15mg, priced at $1,498/month.
- Compounded NAD+ Longevity Treatment Compounded NAD+ (nicotinamide adenine dinucleotide) wellness therapy, a naturally occurring coenzyme involved in cellular energy production and repair, prescribed as part of a clinically supervised wellness program by OrderlyMeds' licensed providers. Available only to existing GLP-1 customers, in 1-month ($224) or 2-month ($448) plans.
- Compounded Sermorelin Longevity Treatment Compounded Sermorelin peptide therapy, a synthetic analog of growth hormone-releasing hormone (GHRH) that interacts with the pituitary gland to support natural growth hormone production, recovery, and lean muscle maintenance. Prescribed by OrderlyMeds' licensed providers and available only to existing GLP-1 customers, at $200/month or $400 for 2 months.
Quantifiable outcome
- Average 15 lbs weight loss on 3-month starter plan
- +4 more outcomes
Companies that use OrderlyMeds
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
OrderlyMeds technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
OrderlyMeds partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- BetterHelpcoreBetterHelp provides online therapy services to OrderlyMeds customers. New customers receive one free month of BetterHelp therapy as part of the $3,700 value of included perks. This partnership addresses the mental health component of weight loss journeys.
- TrainerizecoreTrainerize powers the fitness app offered to OrderlyMeds customers, providing workout plans, exercise tracking, and direct trainer support to help maintain healthy lifestyles during GLP-1 treatment.
- Trifecta NutritionminorTrifecta offers GLP-1 friendly meal delivery with 50% off first order and 15% off subsequent orders for OrderlyMeds customers, supporting nutrition goals during weight loss treatment.
- GLP-1 EnhancedminorGLP-1 Enhanced provides educational nutrition guides ($100 off GLP-1 Nutrition Blueprint and Mastering Your Taper guides) to help customers optimize nutrition and learn how to transition off GLP-1 medications.
- PerfectRx/PerfectionRxcore503A designated compounding pharmacy partner that prepares customized GLP-1 and GLP-1/GIP medications for OrderlyMeds patients. Adheres to USP standards and FDA regulations.
- SmartPharmaRxcore503A designated compounding pharmacy partner operating in the U.S., preparing customized GLP-1 medications for OrderlyMeds patients with rigorous testing for sterility and potency.
- Casacore503A designated compounding pharmacy partner preparing customized GLP-1 medications for OrderlyMeds patients in the U.S.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
OrderlyMeds competitors and assessment
Company assessmentDirect peers
- Ro: Ro is a direct-to-consumer telehealth company offering weight loss via branded and compounded GLP-1s through its Body Program, with provider consultations, home delivery, and ongoing coaching. Ro is directly comparable to OrderlyMeds in business model (DTC, subscription, telehealth-prescribed GLP-1s) and overlaps heavily on customer segment.
- PlushCare: PlushCare is a telehealth provider (acquired by Accolade) offering online weight loss visits, GLP-1 prescriptions, and ongoing care from licensed physicians. It is a direct peer in online physician-prescribed obesity care, though it leans more on insurance billing than OrderlyMeds' cash-pay model.
- Hims & Hers Health: Hims & Hers is a public direct-to-consumer telehealth platform offering prescription and OTC treatments, with a fast-growing GLP-1 weight loss program. It is the closest scaled competitor to OrderlyMeds, using a similar subscription telehealth model with online consultations, shipped medication, and bundled support services, and operates at materially larger scale with insurance partnerships.
- Calibrate: Calibrate is a clinician-guided, online metabolic health program combining GLP-1 medication with coaching on food, sleep, exercise, and emotional health. Its bundled medication-plus-coaching structure mirrors OrderlyMeds' support ecosystem model, even though Calibrate is more insurance-aligned.
- Found: Found is a DTC weight care company prescribing branded and compounded GLP-1 medications alongside provider coaching and behavioral support. It is a direct peer to OrderlyMeds in telehealth-based obesity care with a similar subscription plus coaching model.
- Henry Meds: Henry Meds is a telehealth platform specializing in compounded GLP-1 weight loss medications with cash-pay pricing, similar to OrderlyMeds. It is a direct peer in compounded semaglutide/tirzepatide prescribing via telehealth, competing for the same price-sensitive cash-pay patient base.
- LifeMD: LifeMD is a telehealth company selling weight management programs that include GLP-1 prescriptions, provider consultations, and home delivery. It directly competes with OrderlyMeds in DTC medical weight loss and overlaps on compounded semaglutide/tirzepatide offerings.
Broad incumbents
- WeightWatchers Clinic (formerly Sequence): WeightWatchers Clinic provides clinician-prescribed GLP-1 medications bundled with the WeightWatchers behavioral program. As an established consumer health brand, it competes with OrderlyMeds in the medication-plus-lifestyle support category and brings significant brand and member-base advantages.
- Eli Lilly (LillyDirect / LillyDirect Pharmacy Solutions): Eli Lilly's DTC platform sells Zepbound directly to consumers and bypasses compounding pharmacies. As the manufacturer of tirzepatide, Lilly is a broad incumbent that competes head-on with OrderlyMeds' core weight loss offering and has the supply and pricing power to disrupt compounders.
- Novo Nordisk (NovoCare): Novo Nordisk's NovoCare program offers Wegovy directly to cash-paying patients at a discounted cash price. As the manufacturer of semaglutide and Wegovy, Novo Nordisk is a broad incumbent that competes with OrderlyMeds' branded and compounded semaglutide tiers.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
OrderlyMeds social profiles
Digital presenceOrderlyMeds compliance and trust
Trust signalCompliance2 records
OrderlyMeds financial estimates
Financial estimateRevenue estimate
Valuation estimate
OrderlyMeds leadership team
Management profileNumber of profiles
Profiles3 records
OrderlyMeds funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OrderlyMeds M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OrderlyMeds
What does OrderlyMeds do?
OrderlyMeds is a direct-to-consumer telemedicine platform that connects individual patients with licensed healthcare providers in all 50 U.S. states to obtain GLP-1 and GLP-1/GIP weight loss medications, including compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound, delivered directly to the patient's door. The all-inclusive monthly subscription bundles provider consultations, medication, syringes, and shipping, and is supplemented by a wellness ecosystem of online therapy, fitness, nutrition, and peer community support. The company recently extended the offering into longevity care with compounded NAD+ and Sermorelin add-on therapies for existing GLP-1 patients.
Is OrderlyMeds a public or private company?
OrderlyMeds is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was OrderlyMeds founded?
OrderlyMeds was founded in 2023. It employs 51 to 100 people.
Where is OrderlyMeds based?
OrderlyMeds is headquartered in Atlanta, United States, in the North America region.
How does OrderlyMeds make money?
Two revenue lines are on record. GLP-1 Medication Sales are the primary driver. The others are affiliate Program.
Who are OrderlyMeds's main competitors?
Direct peers on record are Ro, PlushCare, Hims & Hers Health, Calibrate, Found, Henry Meds and LifeMD. Broad incumbents are WeightWatchers Clinic (formerly Sequence), Eli Lilly (LillyDirect / LillyDirect Pharmacy Solutions) and Novo Nordisk (NovoCare).
Does OrderlyMeds have an API?
No public API is recorded for OrderlyMeds.
What industry is OrderlyMeds in?
OrderlyMeds's product category is Direct-to-consumer telemedicine weight management. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAIAH, Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing. Its NAICS code is 6211 and its SIC code is 8000.